Want to see IN:CHEMPLASTS full AI Analyst Report?
Top Page
Chemplast Sanmar Limited
(CHEMPLASTS)
Select Model
Select Model
Rating:44Neutral
Price Target:
₹193.00
▼(-15.89% Downside)
Action:Reiterated
Date:09/23/26
The score is mainly held down by weak financial performance—recent net losses and persistently negative free cash flow—alongside valuation signals impacted by a negative P/E. Technicals provide only partial support, with short-term strength above the 20/50-day averages but a still-weak longer-term trend below the 100/200-day averages.
Positive Factors
Diversified product portfolio
The company participates across PVC, chlorochemicals and specialty intermediates rather than relying on one product line. This breadth gives it exposure to several industrial applications and allows product mix and capacity utilization to influence performance over the next several quarters.
Negative Factors
Persistent net losses
Net losses across 2024–2026 and renewed negative operating profit show that the earnings deterioration is not limited to a single reporting period. Continued operating losses can weaken retained capital, reduce reinvestment capacity, and delay a durable recovery in shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified product portfolio
The company participates across PVC, chlorochemicals and specialty intermediates rather than relying on one product line. This breadth gives it exposure to several industrial applications and allows product mix and capacity utilization to influence performance over the next several quarters.
Read all positive factors
Chemplast Sanmar Limited (CHEMPLASTS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹31.17B
Dividend YieldN/A
Average Volume (3M)48.18K
Price to Earnings (P/E)―
Beta (1Y)0.38
Revenue Growth-1.22%
EPS Growth-97.08%
CountryIN
Employees1,399
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)-39.46
Shares Outstanding158,109,570
10 Day Avg. Volume58,957
30 Day Avg. Volume48,179
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)14.68
Price to Sales (P/S)6.10
P/FCF Ratio-111.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-11.33
Revenue Forecast (FY)₹49.51B
Chemplast Sanmar Limited Business Overview & Revenue Model
Company Description
Chemplast Sanmar Limited is an Indian enterprise primarily involved in the creation and distribution of specialized chemical products. Their extensive range of offerings includes unique paste-grade PVC resins, alongside a variety of custom-made ch...
How the Company Makes Money
Chemplast Sanmar makes money primarily by manufacturing and selling chemicals and polymer products across three main revenue streams: (1) PVC and related products: revenue is generated from the sale of suspension PVC resin and PVC paste resin (use...
Chemplast Sanmar Limited Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
46
Neutral
Cash Flow
32
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.49B | 42.24B | 43.46B | 39.16B | 49.41B | 58.85B |
| Gross Profit | 9.67B | 10.72B | 15.93B | 11.10B | 17.29B | 20.87B |
| EBITDA | 425.10M | 1.62B | 2.19B | 1.06B | 4.68B | 12.54B |
| Net Income | -3.91B | -2.80B | -1.10B | -1.58B | 1.52B | 6.49B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 63.15B | 65.03B | 60.30B | 58.37B | 56.01B |
| Cash, Cash Equivalents and Short-Term Investments | 4.32B | 5.33B | 5.87B | 7.31B | 11.30B | 10.21B |
| Total Debt | 0.00 | 19.52B | 18.42B | 15.48B | 10.19B | 8.81B |
| Total Liabilities | -17.55B | 45.61B | 44.35B | 43.30B | 39.78B | 38.96B |
| Stockholders Equity | 17.55B | 17.55B | 20.68B | 17.01B | 18.58B | 17.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.30B | -2.11B | -8.64B | -641.60M | 7.88B |
| Operating Cash Flow | 0.00 | 859.40M | 1.72B | -2.45B | 3.55B | 9.01B |
| Investing Cash Flow | 0.00 | -2.57B | -4.07B | -5.24B | -2.17B | 1.08B |
| Financing Cash Flow | 0.00 | 468.60M | 660.90M | 3.82B | -269.90M | -3.13B |
Chemplast Sanmar Limited Technical Analysis
Positive
229.45
Price Trends
184.54
Positive
197.25
Positive
227.24
Negative
Market Momentum
5.23
Negative
66.25
Neutral
78.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMPLASTS, the sentiment is Positive. The current price of 229.45 is above the 20-day moving average (MA) of 185.36, above the 50-day MA of 184.54, and above the 200-day MA of 227.24, indicating a neutral trend. The MACD of 5.23 indicates Negative momentum. The RSI at 66.25 is Neutral, neither overbought nor oversold. The STOCH value of 78.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMPLASTS.
Chemplast Sanmar Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹37.03B | 7.38 | ― | 2.93% | -3.37% | -13.58% | |
73 Outperform | ₹149.93B | 31.78 | ― | 1.28% | -2.27% | 38.33% | |
60 Neutral | ₹44.43B | 67.82 | ― | 2.87% | 7.07% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₹157.17B | -7.26 | ― | 1.78% | 2.04% | -742.43% | |
47 Neutral | ₹57.20B | 60.22 | ― | 0.53% | -0.43% | -38.53% | |
44 Neutral | ₹31.17B | -5.33 | ― | ― | -1.22% | -97.08% |
* General Sector Average
IN:CHEMPLASTS
Chemplast Sanmar Limited
210.80
-161.40
-43.36%
IN:ACI
Archean Chemical Industries Ltd.
474.95
-178.22
-27.29%
IN:GHCL
Ghcl Limited
408.95
-183.53
-30.98%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
616.35
76.07
14.08%
IN:SPLPETRO
Supreme Petrochem Limited
820.05
23.95
3.01%
IN:TATACHEM
Tata Chemicals Limited
616.60
-291.45
-32.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.